Viewing Study NCT00079495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2026-02-20 @ 4:44 PM
Study NCT ID: NCT00079495
Status: COMPLETED
Last Update Posted: 2008-03-21
First Post: 2004-03-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)
Sponsor: Neurocrine Biosciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MS View
None Autoimmune disease View
None relapsing View
None progressive View
None Myelin View
None Myelin Basic Protein View
None MBP View
None acute fulminating View
None chronic progressive View
None Altered Peptide Ligand View
None APL View
None Neurocrine View
None NBI-5788 View
None Relapse View